Howard G. Welgus

Director

Howard G. Welgus (Director) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $302K of ARQT (10,000 sh × $30.21, as filed), executed Dec 1 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 11 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.3M

shares × price, as filed

Last traded

Sep 15

Filed Sep 17

Median ADV $51.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names

ARQT

Arcutis Biotherapeutics, Inc. ARQT · 0 buys · 20 sells 20 filings

Recent filings

ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $114K
4,730 sh × $24.18
Exec Sep 15
Filed Sep 17 · 4:06 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $124K
4,730 sh × $26.18
Exec Aug 17
Filed Aug 19 · 4:57 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $127K
4,730 sh × $26.91
Exec Jul 15
Filed Jul 17 · 4:01 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $164K
7,144 sh × $22.99
Exec May 1
Filed May 5 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $239K
10,000 sh × $23.88
Exec Apr 1
Filed Apr 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $256K
10,000 sh × $25.65
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $250K
10,000 sh × $25.05
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $290K
10,000 sh × $28.96
Exec Jan 2
Filed Jan 6 · 5:30 PM ET More filings →